June 11-12, 2019 | Morocco

NORPHEX serves as a primary platform for both local and International companies to exhibit and participate in a dedicated event focused on pharmaceutical manufacturing in North, West & sub-Saharan Africa. With a conference dedicated to exploring partnerships, driving technology and process, NORPHEX will be held in the perfect location to sell more of your products and services in an already lucrative and established market place with established links further into the Africa pharma sector. Around 2,000 visitors, over 40 speakers and more than 120 exhibitors from at least 40 countries are expected to attend the event.


Interested in learning more? Visit for more information.


Global Ethnomedicine and Ethnopharmacology Conference (GEEC)

January 17-18, 2023 | UK

Global Ethnomedicine and Ethnopharmacology Conference aims to discuss ongoing developments and new ideas with scholars, researchers, and notable global figures. This will elevate your career, help you build a new network, and present your individual thoughts relating to Medicine


February 22-24, 2023 | USA

The increasing incidence of cancer and the ever-rising demand for anticancer drugs results in significant growth for the highly potent active pharmaceutical ingredients (HPAPIs) market. The highly toxic properties of HPAPIs, however, present manufacturing and handling challenges.

The Association for Accessible Medicines (AAM) Annual Meeting

February 13-15, 2023 | USA

AAM’s annual meeting Access! 2023 is where policymakers, influential speakers and industry leaders come together to collaborate, exchange ideas and chart the future of generics and biosimilars. You’ll hear firsthand from world-renowned speakers and learn about the critical business, breakthroughs and politics shaping our industry.

Genotoxic Impurities in Pharmaceuticals Summit

March 9-10, 2023 | UK

For the transformation of starting material into the product is needed API synthesis, which involves multiple reaction steps, including reagents, intermediates, catalysts, solvents and others. As a result, low levels of by-products may appear in API as impurities.